The tweet was deleted by the author.
But we saved everything 🙂.
Acadia Pharmaceuticals has exceeded 1 billion dollars in annual revenue for the first time, marking a significant milestone celebrated with the ringing of the Opening Bell at the Nasdaq Exchange.
The company highlighted continued progress in transforming scientific innovations into new therapies, underscoring its commitment to growth and advancement in the pharmaceutical sector.
Acadia’s achievement follows a series of strategic engagements in the sector, including its participation at the Stifel 2026 Virtual CNS Forum to address advancements in central nervous system therapies and a presence at the ACMG Annual Clinical Genetics Meeting in Baltimore, where the company showcased its commitment to genetic research. These initiatives highlight Acadia’s broader effort to drive innovation alongside sustained financial momentum.